Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB
· Real-Time Price · USD
5.50
-0.06 (-1.08%)
At close: Sep 05, 2025, 3:59 PM
5.50
0.00%
After-hours: Sep 05, 2025, 04:32 PM EDT
-1.08% (1D)
| Bid | 5.36 |
| Market Cap | 428.28M |
| Revenue (ttm) | 3.12M |
| Net Income (ttm) | -154.08M |
| EPS (ttm) | -2.79 |
| PE Ratio (ttm) | -1.97 |
| Forward PE | -2.99 |
| Analyst | Buy |
| Ask | 5.76 |
| Volume | 1,136,182 |
| Avg. Volume (20D) | 1,390,337 |
| Open | 5.63 |
| Previous Close | 5.56 |
| Day's Range | 5.39 - 5.74 |
| 52-Week Range | 2.41 - 8.65 |
| Beta | 2.44 |
About SLDB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SLDB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SLDB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
+10.6%
Solid Biosciences shares are trading higher after ...
Unlock content with
Pro Subscription
1 month ago
+8.51%
Solid Biosciences shares are trading higher after the company announced it received FDA Fast Track Designation status for SGT-501 gene therapy.
